GASTROESOPHAGEAL JUNCTION CARCINOMA
Clinical trials for GASTROESOPHAGEAL JUNCTION CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION CARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug INCB123667 enters human trials for Hard-to-Treat cancers
Disease control OngoingThis early-stage trial is testing a new drug called INCB123667, taken as a tablet, in people with advanced solid tumors that have not responded to standard treatments. The study will first test the drug alone, then in combination with other cancer therapies. The main goals are to…
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New antibody drug takes on advanced cancers in first human trial
Disease control OngoingThis early-phase trial is testing a new drug called NTX-1088, which targets a protein on cancer cells, either alone or combined with the immunotherapy pembrolizumab. The study involves 90 people with advanced solid tumors that have spread or cannot be removed. The main goals are …
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: PHASE1 • Sponsor: Nectin Therapeutics Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC